Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Edition
European
US
Microbiology & Infectious Diseases
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Unusual Yeast Fungaemia Patterns Seen in Injection Drug Users
July 2025
French researchers report distinct fungal species in intravenous drug users with yeast fungaemia, suggesting the need for tailored care strategies.
Read more
6 Jun 2025
Is Short-Course Tuberculosis Treatment Ready for Practice?
Participants were randomised to receive either the WHO-recommended 24-week standard regimen or one of four novel 8-week regimens.
5 Jun 2025
Arbovirus Diagnostic Algorithm Reveals Infection Hotspots
A new study from Southeast Europe reveals important insights into the prevalence and transmission patterns of four arboviruses.
4 Jun 2025
Respiratory Microbiota Shifts with COVID-19 Severity Progression
New research reveals that the composition of the lower respiratory tract microbiota is closely linked to COVID-19 severity.
1 Jun 2025
ESPID 2025: Two-Dose Pneumococcal Vaccine Still Effective in Gambia Trial
New findings indicate that a two-dose primary schedule without booster can provide sufficient protection in high-transmission, resource-limited settings.
31 May 2025
ESPID 2025: Expanded Antibiotic Policy Reduces Severe Group A Streptococcal Infections
This is the first real-world evidence that expanded prophylactic antibiotic use can reduce community transmission of iGAS.
31 May 2025
ESPID 2025: Maternal RSV Vaccine Cuts Infant Admissions in Argentina
Preliminary surveillance data from Argentina’s national maternal RSV vaccination programme show a marked reduction in infant hospitalisations during the 2024 RSV season.
30 May 2025
ESPID 2025: Cell-Based Influenza Vaccine Offers Better Protection in Children
New data from a large paediatric cohort suggest that cell-based influenza vaccines provide improved protection over egg-based formulations.
30 May 2025
ESPID 2025: Spain’s Infant Antibody Programme Outperforms UK Maternal Vaccine
A comparison of national RSV prevention strategies has shown that monoclonal antibody immunisation in Spain was vastly more effective than maternal vaccination in the UK.
Loading posts...
« Previous
1
2
3
4
5
…
29
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View